Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultralow Dose PAH Binary Mixture Study

NCT03631667 is registered in ClinicalTrials.gov with Oregon State University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultralow Dose PAH Binary Mixture Study
Lead sponsor
Oregon State University
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2018
Completion date
February 1, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

environmental exposure